Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial

AIMS: To compare the safety and efficacy of fast‐acting insulin aspart (faster aspart) with conventional insulin aspart (IAsp) in adults with type 1 diabetes (T1D). MATERIALS AND METHODS: onset 1 was a randomized, multicentre, treat‐to‐target, phase III, 52‐week (initial 26 weeks + additional 26 wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathieu, Chantal, Bode, Bruce W., Franek, Edward, Philis‐Tsimikas, Athena, Rose, Ludger, Graungaard, Tina, Birk Østerskov, Anne, Russell‐Jones, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947306/
https://www.ncbi.nlm.nih.gov/pubmed/29316130
http://dx.doi.org/10.1111/dom.13205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947306/
https://www.ncbi.nlm.nih.gov/pubmed/29316130
http://dx.doi.org/10.1111/dom.13205

Ejemplares similares